Oxidative stress in vascular disease and its pharmacological prevention

Huige Li1, Sven Horke, Ulrich Förstermann

  • 1Department of Pharmacology, Johannes Gutenberg University Medical Center, Obere Zahlbacher Strasse 67, 55131 Mainz, Germany.

Insights

Cardiovascular risk factors increase reactive oxygen species (ROS), leading to oxidative stress and potential atherogenesis. Pharmacological interventions targeting ROS production and enhancing antioxidant defenses offer therapeutic strategies for vascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Oxidative Stress Research
  • Pharmacology

Background:

  • Cardiovascular risk factors elevate reactive oxygen species (ROS) production via enzymes like NADPH oxidase and xanthine oxidase.
  • Imbalance between ROS generation and antioxidant defenses (e.g., superoxide dismutase, catalase) causes oxidative stress, a key factor in atherogenesis.
  • Dysfunctional endothelial nitric oxide synthase (eNOS) also contributes to oxidative stress in vascular disease.

Purpose of the Study:

  • To review the molecular mechanisms underlying oxidative stress induction in pathological conditions.
  • To summarize established and novel pharmacological approaches for preventing oxidative stress and vascular disease.
  • To highlight the therapeutic potential of targeting ROS production and enhancing antioxidant capacity.

Main Methods:

  • Literature review of studies on oxidative stress mechanisms in cardiovascular disease.
  • Analysis of established drugs (e.g., ACEIs, ARBs, statins) and novel agents (e.g., resveratrol, mitochondria-targeted antioxidants).
  • Examination of molecular targets and pathways involved in ROS generation and antioxidant defense.

Main Results:

  • Cardiovascular risk factors significantly enhance ROS production, overwhelming endogenous antioxidant systems.
  • Pharmacological agents including ACE inhibitors, ARBs, statins, nebivolol, PETN, resveratrol, and mitochondria-targeted antioxidants demonstrate potential in mitigating oxidative stress.
  • These interventions target key enzymes in ROS generation and support antioxidant pathways, offering therapeutic benefits.

Conclusions:

  • Oxidative stress is a critical mediator in the development of vascular disease.
  • Targeting ROS production and bolstering antioxidant defenses pharmacologically presents a promising therapeutic strategy.
  • Further research into these pharmacological interventions may lead to improved prevention and treatment of cardiovascular diseases.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...